Rapid progression of condyloma acuminatum caused by IL-17A antibody treatment: a case report.
Front Med (Lausanne)
; 11: 1387620, 2024.
Article
in En
| MEDLINE
| ID: mdl-38813385
ABSTRACT
Anti interleukin (IL)-17A therapy is a common and effective treatment for psoriasis, but there are also risks of infection. In this case, we presented a patient who experienced a swift progression of condyloma acuminatum on the genitals during psoriasis treatment with secukinumab, a human IL-17A antagonist. Through this case, we strongly suspect that anti IL-17A treatment may promote the onset and rapid progression of low-risk HPV-associated condyloma acuminatum.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Front Med (Lausanne)
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: